Humacyte GAAP EPS of -$0.11 beats by $0.05, revenue of $0.75M misses by $0.17M
Source: SeekingAlpha
2025-11-12 07:29:14 ET
More on Humacyte
- Humacyte: Shares Tank On Fundraising News - What You Need To Know
- Humacyte Q3 2025 Earnings Preview
- Humacyte shares sink as it announces pricing of $60M direct offering
- Seeking Alpha’s Quant Rating on Humacyte
- Historical earnings data for Humacyte
Read the full article on Seeking Alpha
For further details see:
Humacyte GAAP EPS of -$0.11 beats by $0.05, revenue of $0.75M misses by $0.17M
Humacyte Inc.
NASDAQ: HUMA
HUMA Trading
3.8% G/L:
$1.2622 Last:
3,780,433 Volume:
$1.22 Open:
HUMA Latest News
February 18, 2026 08:00:00 am
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
February 09, 2026 08:00:00 am
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
HUMA Stock Data
$220,166,898
198,988,939
0.6%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
